“…6,7) Recently we have developed several MAOS methodologies to obtain pyrazolo [3,4-b] pyridines, 2,[8][9][10][11][12][13] since they are an important group of nitrogen-containing fused heterocycles useful for medicinal and organic chemistry with a wide spectrum of biological and pharmacological activities [14][15][16] as antibacterial, antidepressant, anti-hyperglycemic, anti-inflammatory, antitumor, and anxiolytic agents and are being used in the treatment of Alzheimer's diseases, drugs addiction, and infertility. 7,[17][18][19][20][21][22][23] To continue within the framework of our interest to develop synthetic strategies to obtain functionalized and biologically interesting pyrazolo[3,4-b] pyridines, we wish to report an efficient MAOS method between N,N-dimethyl-N′-pyrazolylformimidamides 2,10,24,25) and β-nitrostyrenes to obtain 5-nitro-1-phenyl-pyrazolo [3,4-b] pyridines. 26,27) Considering that this type of compounds have previously shown good antimicrobial activities, including antifungal properties against Saccharomyces cerevisiae and Candida albicans, [28][29][30][31][32][33] we tested the new series of 5-nitro-1-phenylpyrazolo [3,4-b] pyridines for antifungal activities against two clinically important fungi C. albicans and Cryptococcus neoformans.…”